Dublin, April 11, 2018 -- The "Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022)" report has been added to ResearchAndMarkets.com's offering.
The global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.
Global market is projected to display a robust growth represented by a CAGR of 4.24% by value during 2017 - 2022, chiefly driven by increase in animal population and rising trend of pet ownership among growing middle class income group coupled with rising awareness of animal health.
Among the type, Tetracycline accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large animal population base, growing trend of pet humanization and expanding middle class income group.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Global Animal Antibiotics and Antimicrobials Market, By Value
- By Product Type - Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others)
- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others
- By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others
- By Type of Animals - Farm Animals, Companion Animals
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Global Antibiotics & Antimicrobials Product Outlook
5. Global Antibiotics & Antimicrobials Market: Growth and Forecast
5.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
5.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
5.3. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value
5.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
5.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
5.4. Global Antibiotics & Antimicrobials & Market - By Product Type, By Value (2012-2022)
5.4.1. Penicillins, By Value (2012-2022)
5.4.2. Fluoroquinolones, By Value (2012-2022)
5.4.3. Aminoglycosides, By Value (2012-2022)
5.4.4. Tetracyclines, By Value (2012-2022)
5.4.5. Macrolides, By Value (2012-2022)
5.4.6. Sulfonamides, By Value (2012-2022)
5.4.7. Lincosamides, By Value (2012-2022)
5.4.8. Cephalosporins, By Value (2012-2022)
5.4.9. Others, By Value (2012-2022)
5.5. Global Antibiotics & Antimicrobials Market- By Animal Type, By Value, (2012-2022)
5.5.1. Farm Animals, By Value (2012-2022)
5.5.2. Companion Animals, By Value (2012-2022)
5.6. Global Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
5.6.1. Premixes, By Value (2012-2022)
5.6.2. Oral Powder, By Value (2012-2022)
5.6.3. Oral Solution, By Value (2012-2022)
5.6.4. Injections , By Value (2012-2022)
5.6.5. Others, By Value (2012-2022)
6. North America Antibiotics & Antimicrobials Market: Growth and Forecast
7. Europe Antibiotics & Antimicrobials Market: Growth and Forecast
8. Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
9. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)
9.1. Rising demand for meat heavy diet and Animal derived products
9.2. Increasing ownership and rising spending on pets
9.3. Increasing risk of Animal Borne infectious Diseases
10. Market Restraints
11. Consolidation of the Industry
12. Porter's Five Forces Analysis - Heart Valve Devices Market
13. SWOT Analysis -Heart Valve Devices Market
14. Policy and Regulations
15. Company Profiles
- Bayer AG
- Boehringer Ingelheim GmbH
- Ceva Sante Animale
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company
- Merck & Co. Inc.
- Phibro Animal Health Corporation
- Vetoquinol S.A.
- Virbac
- Zoetis Inc.
For more information about this report visit https://www.researchandmarkets.com/research/j6hspt/global_animal?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Animal Healthcare/Veterinary, Animal Pharmaceuticals


Amazon Secures 200 MW Wind Power Deals in Sweden
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Toyota Global Sales Fall as China Demand Slumps
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Honda, Nissan Eye Shared Vehicle Software Platform by 2029
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
OpenAI AI Agent Swarm Behind Hugging Face Hack
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 



